Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma

Indian Journal of Medical Research

Volumn 133, Issue 4, 2011, Pages 381-386

  Das, Satya N ^a   Khare, Pratima ^b   Singh, Manoj K ^a   Sharma, Suresh C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Department of Pathology   (India)

Author keywords

Cyclin D1; DNA ploidy; Oral cancer

Indexed keywords

CELL NUCLEUS DNA; CYCLIN D1; DNA;

ADULT; AGED; ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; BIOPSY; CANCER STAGING; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TOBACCO; TOBACCO RELATED INTRAORAL SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANEUPLOIDY; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CYCLIN D1; DIPLOIDY; DNA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TOBACCO, SMOKELESS;

EID: 79955742671     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. GLOBOCAN. Cancer incidence, mortality and prevalence world-wide. Lyon: IARC Press; 2002.
2. Khanna NN, Srivastava PK, Khanna S, Das SN. Intensive chemotherapy for cancer of the oral cavity. Cancer 1983; 52: 790-3.
3. Blagosklonny M V, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002; 1: 103-10.
4. Diehl JA. Cycling to cancer with Cyclin D1. Cancer Biol Ther 2002; 1: 226-31.
5. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases and CDK inhibitors in human cancer. Adv Cancer Res 1996; 68: 67-108.
6. Staibano S, Muzio LL, Pannone G, Mezza E, Argenziano G, Vetrani A, et al. DNA ploidy and cyclin D1 expression in basal cell carcinoma of head and neck. Am J Clin Pathol 2001; 115: 805-13.
7. Gimnez-Conti IB, Collet AM, Lanfranchi H, Itoiz ME, Luna M, Xu HJ, et al. P53, Rb, and cyclin D1 expression in human oral verrucous carcinomas. Cancer 1996; 78: 17-23.
8. Xu J, Gimenez-Conti IB, Cunningham JE, Collet AM, Luna MA, Lanfranchi HE, et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998; 83: 204-12.
9. De Rosa I, Staibano S, Lo Muzio L, Delfno M, Lucariello A, Coppola A, et al. Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med 1999; 28: 252-8.
10. Dong Y, Sui L, Sugimoto K, Tai Y, Tokuda M. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer (Pred Oncol) 2001; 95: 209-15.
11. Lamb J, Ewen ME. Cyclin D1 and molecular chaperones: implications for tumorigenesis. Cell Cycle 2003; 2: 525-7.
12. Lin HS, Berry GJ, Sun Z, Fee WE Jr. Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol 2006; 4: 62.
13. Das SN, Khare P, Patil, A, Pandey RM, Singh MK, Shukla NK. Association of DNA pattern of metastatic lymphnode with disease free survival in patients with intraoral squamous cell carcinoma. Indian J Med Res 2005; 122: 214-21.
14. rd ed. Philadelphia: J.B. Lippincott; 1988. p. 27-32.
15. Hood DL, Petras RE, Edinger M, Fazio V, Tubbs RR. Deoxy-ribonucleic acid ploidy and cell cycle analysis of colorectal carcinoma by fow cytometry:A prospective study of 137 cases using fresh whole cell suspension. Am J Clin Pathol 1990; 93: 615-20.
16. Michalides R, VanVeelen N, Hart A, Loftus B, Wientjens E, Balm A. Over- expression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995; 55: 975-8.
17. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 1996; 78: 390-5.
18. Mineta H, Borg A, Dictor M, Wahlberg P, Wennerberg J. Correlation between p53 mutation and cyclin D1 amplifcation in head and neck squamous cell carcinoma. Oral Oncol 1997; 33: 42-6.
19. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-7.
20. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10: 775-8.
21. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, et al. Cyclin- D1- gene amplifcation is a more potent prognostic factor than its protein over-expression in human head and neck squamous-cell carcinoma. Int J Cancer 1997; 74: 576-81.
22. Mishra R, Das BR. Cyclin D1 expression and its possible regulation in chewing tobacco-mediated oral squamous cell carcinoma progression. Arch Oral Biol 2009; 54: 917-23.
23. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM, et al. Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 2000; 22: 234-40.
24. Nagasawa S, Onda M, Sasajima K, Makino H, Yamashita K, Takumo K, et al. Cyclin D1 overexpression as a Prognostic Factor in patients with esophageal carcinoma. J Surg Oncol 2001; 8: 208-14.
25. Huang XM, Dai CB, Mou ZL, Wang LJ, Wen WP, Lin SG, et al. Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: Implication for therapy. Cancer Lett 2009; 28: 47-56.
26. Mishra R, Das BR. Activation of STAT5-cyclin D1 pathway in chewing tobacco-mediated oral squamous cell carcinoma Mol Biol Rep 2005; 32: 159-66.
27. Wang MB, Yip HT, Srivatsan ES. Antisense Cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Laryngoscope 2001; 111: 982-8.
28. Akervall J, Kurnit DM, Adams M, Zhu S, Fisher SG, Bradford CR, et al. Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck. Acta Otolaryngol 2004; 124: 851-7.
29. Tanner MM, Karhu RA, Nupponen NN, Borg A, Baldetorp B, Pejovic T, et al. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplifcation of cyclin D1 oncogene. Am J Pathol 1998; 153: 191-9.